HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Addolorato Selected Research

Baclofen

1/2020Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows.
12/2018Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.
1/2018The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
1/2018Alcohol addiction - the safety of available approved treatment options.
1/2018Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
4/2013Management of alcohol dependence in patients with liver disease.
2/2013A human laboratory pilot study with baclofen in alcoholic individuals.
5/2011Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
3/2010Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.
1/2010Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Addolorato Research Topics

Disease

40Alcoholism (Alcohol Abuse)
01/2022 - 01/2004
10Liver Diseases (Liver Disease)
01/2022 - 11/2009
6Fibrosis (Cirrhosis)
03/2018 - 01/2006
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 03/2003
6Substance Withdrawal Syndrome (Withdrawal Symptoms)
02/2014 - 09/2003
4Alcoholic Hepatitis
01/2022 - 07/2009
4Celiac Disease (Celiac Sprue)
11/2009 - 04/2005
3Alcoholic Liver Diseases (Alcoholic Liver Disease)
03/2018 - 12/2011
3Alcohol Withdrawal Delirium (Delirium Tremens)
03/2005 - 09/2003
2Bacterial Infections (Bacterial Infection)
04/2021 - 03/2020
2Sepsis (Septicemia)
04/2021 - 03/2020
2Necrosis
01/2020 - 12/2018
2Inflammation (Inflammations)
12/2018 - 01/2011
2Neoplasms (Cancer)
03/2018 - 05/2009
2Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
03/2018 - 07/2010
2Borderline Personality Disorder (Personality Disorders, Borderline)
03/2016 - 01/2014
2End Stage Liver Disease
01/2016 - 09/2013
2Social Phobia
07/2015 - 01/2008
2Substance-Related Disorders (Drug Abuse)
01/2012 - 09/2002
2Atrophy
11/2009 - 01/2008
2Body Weight (Weight, Body)
04/2008 - 04/2005
2Hepatolenticular Degeneration (Wilson's Disease)
10/2007 - 01/2006
2Migraine Disorders (Migraine)
03/2003 - 05/2002
1Infections
01/2022
1COVID-19
01/2022
1Cerebral Infarction
10/2021
1Varicose Veins (Varicose Vein)
10/2021
1Patent Foramen Ovale
10/2021
1Cocaine-Related Disorders (Cocaine Addiction)
01/2021
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
11/2020
1Mood Disorders (Mood Disorder)
01/2020
1Sleep Wake Disorders
08/2019
1Malnutrition (Nutritional Deficiencies)
01/2019
1Chemical and Drug Induced Liver Injury
05/2018
1Opioid-Related Disorders (Opiate Addiction)
11/2016
1Constipation
11/2016
1Mental Disorders (Mental Disorder)
03/2016
1Hallucinations (Hallucination)
03/2015
1Neurologic Manifestations (Neurological Manifestations)
03/2014

Drug/Important Bio-Agent (IBA)

19BaclofenFDA LinkGeneric
01/2020 - 09/2003
8Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
11/2021 - 09/2005
7Pharmaceutical PreparationsIBA
03/2016 - 09/2002
4Peptides (Polypeptides)IBA
03/2020 - 03/2009
4GhrelinIBA
03/2012 - 04/2005
3Biomarkers (Surrogate Marker)IBA
03/2020 - 06/2012
34-hydroxybutyric acidIBA
03/2016 - 02/2005
3gamma-Aminobutyric Acid (GABA)IBA
01/2014 - 06/2011
3Topiramate (Topamax)FDA LinkGeneric
04/2013 - 02/2005
3GABA-B ReceptorsIBA
01/2010 - 01/2004
3Glutens (Glutelin)IBA
11/2009 - 10/2007
3Hormones (Hormone)IBA
03/2009 - 08/2008
2ProcalcitoninIBA
04/2021 - 03/2020
2LipopolysaccharidesIBA
01/2020 - 12/2018
2GABA-B Receptor AgonistsIBA
02/2013 - 03/2010
2Biological ProductsIBA
02/2011 - 01/2010
2CholesterolIBA
06/2008 - 10/2007
1CyanoacrylatesIBA
10/2021
1Vitamin DFDA LinkGeneric
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
03/2020
1InterleukinsIBA
01/2020
1ElectrolytesIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020
1BenzodiazepinesIBA
08/2019
1Transaminases (Aminotransferases)IBA
12/2018
1EndotoxinsIBA
12/2018
1Alkaline PhosphataseIBA
05/2018
1BilirubinIBA
05/2018
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2017
1Methadone (Dolophine)FDA LinkGeneric
11/2016
1Opioid Analgesics (Opioids)IBA
11/2016
1Buprenorphine (Subutex)FDA LinkGeneric
11/2016
1nalmefene (Revex)FDA Link
04/2016
1Antipsychotic Agents (Antipsychotics)IBA
03/2015
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2015
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
01/2015
1Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)IBA
01/2015
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2015
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2015
1Thyroid HormonesIBA
01/2015
1PotassiumIBA
03/2014
1Butyric Acid (Butanoic Acid)IBA
01/2014
1Disulfiram (Antabuse)FDA Link
11/2013
1Naltrexone (ReVia)FDA LinkGeneric
11/2013
1Acamprosate (Campral)FDA Link
11/2013
1Ondansetron (Zofran)FDA LinkGeneric
04/2013
1Dopamine Receptors (Dopamine Receptor)IBA
02/2013

Therapy/Procedure

8Liver Transplantation
01/2022 - 01/2011
7Therapeutics
01/2022 - 01/2003
7Gluten-Free Diet
11/2009 - 01/2003
6Drug Therapy (Chemotherapy)
03/2014 - 01/2010
3Transcranial Magnetic Stimulation
01/2021 - 01/2012
2Transplantation
03/2018 - 09/2013
2Phytotherapy (Herbal Therapy)
06/2009 - 08/2006
2Complementary Therapies (Alternative Medicine)
02/2008 - 08/2006
1Length of Stay
01/2019
1Opiate Substitution Treatment
11/2016
1Bariatric Surgery
07/2015
1Secondary Prevention
02/2014